Healthcare -
Biotechnology - NASDAQ - US
$ 53.55
-0.557 %
$ 6.6 B
Market Cap
14.24
P/E
HALO - NET INCOME
Net Income HALO - Halozyme Therapeutics, Inc.
444 M
LAST VALUE
48.23%
2 YEAR CAGR
52.13%
5 YEAR CAGR
23.86%
10 YEAR CAGR